Gladius Capital Management »

Pacira Pharmaceuticals shares owned by Gladius Capital Management

Quarter-by-quarter ownership of Pacira Pharmaceuticals (PCRX) shares owned by Gladius Capital Management from 13F filings

Historical chart of Gladius Capital Management investment in Pacira Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Pacira Pharmaceuticals held by Gladius Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pacira Pharmaceuticals by Gladius Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $23k 1.5k 15.05

More positions owned by Gladius Capital Management

Spdr S&p 500 Etf Tr Put Put Option
Apple Put Put Option
Microsoft Corp Put Put Option
Nvidia Corporation Put Put Option
Alphabet Put Put Option
Amazon Put Put Option
Meta Platforms Put Put Option
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Berkshire Hathaway Inc Del Put Put Option
Broadcom Put Put Option
Tesla Put Put Option
Eli Lilly & Co Put Put Option
Amazon (AMZN)

View all positions for Gladius Capital Management

Top funds holding Pacira Pharmaceuticals

BlackRock
BlackRock
Vanguard Group
Pacer Advisors
Renaissance Technologies
D. E. Shaw & Co
State Street Corporation
Dimensional Fund Advisors
Doma Perpetual Capital Management
Macquarie Group
Arrowstreet Capital, Limited Partnership
Geode Capital Management
Invesco
Rock Springs Capital Management
Jpmorgan Chase & Co

View all funds holding Pacira Pharmaceuticals